Scandinavian ChemoTech AB Series B (CMOTEC-B) — Net Asset Quality Index
Scandinavian ChemoTech AB Series B (CMOTEC-B) has a Net Asset Quality Index of 13.8% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of Skr11.01 Million minus total liabilities of Skr9.49 Million yields net assets of Skr1.52 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read Scandinavian ChemoTech AB Series B total liabilities for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Scandinavian ChemoTech AB Series B Net Asset Quality Index Over Time (2014–2025)
This chart shows how Scandinavian ChemoTech AB Series B's Net Asset Quality Index has evolved across 12 annual periods from 2014 to 2025. As of June 2026, the index stands at 13.8%, representing net assets of Skr1.52 Million against total assets of Skr11.01 Million SEK. For live market cap and overall valuation, see Scandinavian ChemoTech AB Series B stock valuation.
Annual Net Asset Quality Index for Scandinavian ChemoTech AB Series B (2014–2025)
The table below presents the year-by-year Net Asset Quality Index for Scandinavian ChemoTech AB Series B from 2014 to 2025, covering 12 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check Scandinavian ChemoTech AB Series B (CMOTEC-B) strategic asset index to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (SEK) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 24.1% | Skr3.19 Million | Skr13.20 Million | Skr10.01 Million | ▼ -20.6 pp |
| 2024 | 44.7% | Skr5.98 Million | Skr13.38 Million | Skr7.40 Million | ▼ -29.5 pp |
| 2023 | 74.2% | Skr11.03 Million | Skr14.87 Million | Skr3.84 Million | ▲ +9.7 pp |
| 2022 | 64.5% | Skr13.99 Million | Skr21.70 Million | Skr7.71 Million | ▼ -28.2 pp |
| 2021 | 92.7% | Skr23.92 Million | Skr25.81 Million | Skr1.89 Million | ▲ +34.9 pp |
| 2020 | 57.8% | Skr9.24 Million | Skr15.99 Million | Skr6.75 Million | ▲ +2.1 pp |
| 2019 | 55.6% | Skr9.73 Million | Skr17.49 Million | Skr7.76 Million | ▼ -34.2 pp |
| 2018 | 89.9% | Skr20.50 Million | Skr22.81 Million | Skr2.31 Million | ▲ +9.8 pp |
| 2017 | 80.1% | Skr10.29 Million | Skr12.84 Million | Skr2.56 Million | ▼ -6.6 pp |
| 2016 | 86.7% | Skr14.58 Million | Skr16.83 Million | Skr2.24 Million | ▲ +73.6 pp |
| 2015 | 13.1% | Skr868.64K | Skr6.65 Million | Skr5.78 Million | ▼ -57.2 pp |
| 2014 | 70.2% | Skr46.27K | Skr65.90K | Skr19.63K | — |